Methotrexate an Old Drug with New Tricks
Centre National de la Recherche Scientifique · Inserm · +4 more institutions
Abstract
Methotrexate (MTX) is the first line drug for the treatment of a number of rheumatic and non-rheumatic disorders. It is currently used as an anchor disease, modifying anti-rheumatic drug in the treatment of rheumatoid arthritis (RA). Despite the development of numerous new targeted therapies, MTX remains the backbone of RA therapy due to its potent efficacy and tolerability. There has been also a growing interest in the use of MTX in the treatment of chronic viral mediated arthritis. Many viruses-including old world alphaviruses, Parvovirus B19, hepatitis B/C virus, and human immunodeficiency virus-have been associated with arthritogenic diseases and reminiscent of RA. MTX may provide benefits although with…
Citation impact
- FWCI
- 26.96
- Percentile
- 100%
- References
- 270
Authors
8- YBYosra Bedoui
Centre National de la Recherche Scientifique, Inserm, Processus Infectieux en Milieu Insulaire Tropical, Institut de Recherche pour le Développement
- XGXavier Guillot
Centre Hospitalier Universitaire de La Réunion
- JSJimmy Sélambarom
Centre National de la Recherche Scientifique, Inserm, Processus Infectieux en Milieu Insulaire Tropical, Institut de Recherche pour le Développement
- PGPascale Guiraud
Centre National de la Recherche Scientifique, Inserm, Processus Infectieux en Milieu Insulaire Tropical, Institut de Recherche pour le Développement
- CGClaude Giry
Centre Hospitalier Universitaire de La Réunion
Topics & keywords
- Medicine
- Rheumatoid arthritis
- Methotrexate
- Drug
- Tolerability
- Immunology
- Immune system
- Pharmacology
- Good health and well-being